Q fever during pregnancy: diagnosis, treatment, and follow-up

Arch Intern Med. 2002 Mar 25;162(6):701-4. doi: 10.1001/archinte.162.6.701.

Abstract

Background: Q fever, caused by Coxiella burnetii, may result in abortions, premature deliveries, and stillbirths in infected pregnant women.

Objective: To evaluate the best treatment strategy for Q fever during pregnancy.

Methods: We evaluated the prognosis of 17 pregnant women who developed Q fever with and without co-trimoxazole (trimethoprim-sulfamethoxazole) treatment.

Results: The outcome of the pregnancy was found to depend on the trimester. Abortions occurred in 7 of 7 insufficiently treated patients infected during the first trimester vs 1 of 5 patients infected later. Co-trimoxazole given until delivery protected against abortion (0/4) but not against the development of chronic infections, and it did not significantly reduce the colonization of the placenta (2/4 vs 4/4).

Conclusions: Our results show that C burnetii infections cause abortion and that women who develop Q fever while pregnant should be treated with co-trimoxazole for the duration of pregnancy, specifically when infected during the first trimester.

MeSH terms

  • Acute Disease
  • Anti-Bacterial Agents / therapeutic use*
  • Chronic Disease
  • Coxiella burnetii / isolation & purification
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications, Infectious / blood
  • Pregnancy Complications, Infectious / diagnosis*
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Outcome
  • Pregnancy Trimesters / drug effects
  • Prognosis
  • Q Fever / blood
  • Q Fever / diagnosis*
  • Q Fever / drug therapy*
  • Serologic Tests
  • Time Factors
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination